Skip to main content

Table 3 Comparison of maternal and fetal complications during pregnancy and the perinatal period

From: Is early-follicular long-acting GnRH agonist protocol an alternative for patients with polycystic ovary syndrome undergoing in vitro fertilization?

 

MLSL

EFLL

RR (95% CI)

P value

 

n = 352

n = 1063

  

PE

12/352 (3.41)

57/1063 (5.36)

1.605 (0.851,3.028)

0.140

ICP

0

4/1063 (0.38)

1.004 (1.000,1.007)

0.566

IDA

1/352 (0.28)

0

0.997 (0.992,1.003)

0.561

GDM

5/352 (1.42)

54/1063 (5.08)

3.714 (1.474,9.360)

0.003

Ectopic pregnancy

21/352 (5.97)

16/1063 (1.51)

0.241 (0.124,0.467)

0.002

Multiple pregnancy

99/352 (28.13)

280/1063 (26.34)

0.914 (0.698,1.196)

0.512

Placenta previa

2/352 (0.57)

2/1063 (0.19)

0.330 (0.046,2.351)

0.559

PROM

10/352 (2.84)

51/1063 (4.79)

1.724 (0.865,3.432)

0.117

Cesarean

212/352 (60.23)

681/1063 (64.06)

1.177 (0.919,1.508)

0.196

Gestational age at birth

37.920 ± 2.350

37.750 ± 2.271

/

0.269

Macrosomia

28/340 (8.24)

100/1095 (9.13)

1.120 (0.723,1.735)

0.612

LBW

80/340 (23.53)

264/1095 (24.11)

1.032 (0.775,1.375)

0.827

Malformation

3/340 (0.88)

9/1095 (0.82)

0.931 (0.251,3.458)

1.000

CHD

1/340 (2.9)

6/1095 (0.55)

1.868 (0.224,15.569)

0.832

  1. Note: Categorical data: n/N (%); 
  2. PE preeclampsia, ICP intrahepatic cholestasis of pregnancy, IDA iron-deficiency anemia, GDM gestational diabetes, PROM premature rupture of membranes, LBW low birth weight, CDH Congenital Heart Disease